Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 3/13/2025Insilico Medicine Secures $110M, Explores IPO Amid AI Drug Discovery B...
  • 3/13/2025China Issues Guidelines for Informatization of County-Level Healthcare...
  • 3/13/2025AskBio Receives FDA Regenerative Medicine Advanced Therapy designation...
  • 3/12/2025NewDEL Biotech Completes Series A+ Financing Led by XtalPi to Accelera...
  • 3/12/2025Novartis' Cosentyx Receives Fifth Indication Approval in China for Hid...
  • 3/12/2025Harbour BioMed Launches Élancé Therapeutics to Advance Next-Generati...
  • 3/12/2025CDE Publicizes the List of Reference Formulations for GQCE Studies (91...
  • 3/12/2025Pfizer's PD-L1 Targeting ADC Receives Clinical Trial Approval in China
  • 3/12/2025Eli Lilly Plans Late 2025 Launch of Weight Loss Drugs in China and Ind...
  • 3/12/2025CSPC Advances Phase II Trial of Nectin-4 ADC SYS6002 for Advanced HNSC...
  • 3/12/2025Akeso Initiates Phase III Trial of Ivonescimab Plus Chemotherapy for m...
  • 3/11/2025Over 100 Chinese Pharma Firms Report Losses as 319 Firms Release 2024 ...
  • 3/11/2025Chinese Scientists Develop Potential Vaccine to Prevent Stroke and Hea...
  • 3/11/2025MindRank's AI-Designed Dual Kinase Inhibitor MRANK-106 Receives FDA IN...
  • 3/11/2025Pfizer's Elrexfio Receives Conditional Approval in China for Advanced ...
  • 3/11/2025Juvensis Secures Over CNY 100M in Pre-A Financing to Advance Gene The...
  • 3/11/2025RockRoc Secures Pre-A+ Financing to Advance Macrophage-Based Cancer Th...
  • 3/11/2025InnoCare Presents Promising Phase II Data on ICP-488 for Psoriasis
  • 3/11/2025TYK Medicines Announces Pivotal Phase II Trial of TY-9591 Vs Osimertin...
  • 3/10/2025Nona Bio Launches AI-Assisted Drug Discovery Platform Hu-mAtrIx
  • 3/10/2025China Approves AbbVie's Skyrizi for Active Crohn's Disease Treatment
  • 3/10/2025China Expands BMI Coverage to Over 90% of Village Clinics
  • 3/10/2025China's Life Expectancy Reaches 79 Years in 2024, Surpassing Health Pl...
  • 3/10/2025China to Expand Mental Health Services Nationwide: Official
  • 3/7/2025Recent Executive Moves
  • 3/7/2025Innovent Launches Phase 2 Trial of IBI362 for Heart Failure Patients w...
  • 3/7/2025Enhua Pharma Acquires 10.4% Stake in NeuroThree with $3.5M Investment...
  • 3/7/2025CStone Submits Clinical Trial Application in Australia for CS5001 in D...
  • 3/6/2025Nhwa Pharma Acquires Stake in Neuro3 to Expand CNS Drug Pipeline  
  • 3/6/2025Bayer Expands Innovation in China with New E-Town Center
  • Page:1/44 Total number of articles:1316: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group